SCHEMBL24252386

SCHEMBL24252386

Cc1nc2c(-c3ccc4c(N)c(OC=O)nnc4c3)cc(B(O)O)cc2o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24252699 0.86 PRMT5 (0.32)
Formic Acid SCHEMBL25243155 0.80
SCHEMBL24252291 0.79 CFD (0.30)
SCHEMBL24252353 0.78 GAA (0.31)
SCHEMBL25243154 0.76
Formic Acid SCHEMBL25266827 0.76
SCHEMBL24252752 0.74 LRRK2 (0.30)
SCHEMBL24252648 0.74 PLG (0.31)
SCHEMBL24252724 0.73 LRRK2 (0.34)
SCHEMBL24252737 0.73 LRRK2 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11814404-B2 Inhibitors of complement factors and uses thereof ANNEXON, INC. (US) 2023-11-14 US disclosed
US-20220048930-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF ANNEXON, INC. 2022-02-17 US disclosed